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Abstract 
 
Introduction:  Serrated polyposis syndrome (SPS) increases colorectal cancer 
(CRC) risk. We describe the numbers of colonoscopies and polypectomies 
performed to achieve and maintain low polyp burdens, and the feasibility of 
expanding surveillance intervals in patients who achieve endoscopic control.    
Methods:  We retrospectively evaluated a prospectively collected database on 115 
SPS patients undergoing surveillance at Indiana University Hospital between June 
2005 and May 2018.  The endoscopist provided surveillance interval 
recommendations based on polyp burden.  Endoscopic control was considered 
successful if surveillance examinations exhibited  fewer polyps and if no or only an 
occasional polyp ≥1 cm in size was present at follow-up.  Initial control was 
designated the clearing phase and the maintenance phase was surveillance after 
control was established.   
Results:  In total, 87 patients (75.7%) achieved endoscopic control, with some 
others in the clearing phase at this writing.  Achieving control required a mean of 
2.84 colonoscopies (including the baseline) over 20.4 months and a mean total 27.9 
polyp resections.  After establishing control, 71 patients were recommended to 
receive ≥24-month follow-up.  Of those, 60 patients (69.0% of patients with initial 
control) continued surveillance at our center.  The mean interval between 
colonoscopies during maintenance was 19.3 months with 6.74 mean polypectomies 
per procedure on polyps primarily <1 cm.   There were no incident cancers or colon 
surgeries during maintenance. 
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Conclusion:   Most patients achieved control of polyp burden with 2 to 3 
colonoscopies over 1 to 2 years. After reaching control, 60 patients returned at 
intervals up to 24 months with no incident cancers and no surgeries required.  
Expansion of surveillance intervals to 24 months is effective and safe for many SPS 
patients who reach control of polyp burden.   
 
 
 
 
 
 
Introduction: 
 
 Serrated polyposis syndrome (SPS), previously referred to as hyperplastic 
polyposis syndrome, is associated with an increased risk of colorectal cancer (CRC)1-
3. The World Health Organization (WHO) criteria include three subtypes of SPS 
(Table 1)4. Patients with SPS are often recommended to undergo annual 
surveillance colonoscopy2. However, most cancers in SPS are identified at the 
prevalence colonoscopy and the risk of cancer during surveillance has been recently 
described as low5,6. 
Polyp burden, a term that generally refers to both increasing number and 
size of polyps, is quite variable in SPS.  Patients with low polyp burden may be 
effectively controlled after a single colonoscopy with polyp resections.  In other 
cases, several colonoscopies are needed (or one or two lengthy colonoscopies), 
using many polyp resections, to bring the polyp burden to a level where short-term 
risk of cancer seems minimal.  In our practice, we often extend the surveillance 
interval beyond 1 year in SPS patients once the number of polyps has been reduced 
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substantially and all large polyps are resected7.  In this report we describe our 
experience with achieving control of polyp burden and expansion of surveillance 
intervals in SPS patients. 
 
 
Materials and Methods:   
 
We retrospectively analyzed a prospectively collected database of 115 SPS 
patients who received treatment at Indiana University Hospital.  The database 
included demographic information and the results of each colonoscopy.   All patients 
were examined with Olympus (Olympus Corporation, Center Valley, Pa, United 
States) colonoscopes by DKR between June 2005 and May 2018.  Colonoscopes in 
Olympus 180 and 190 series were universally high-definition instruments. Patients 
were usually referred by other colonoscopists outside the institution for polyp 
resection, though some were recognized as SPS patients during routine screening or 
surveillance colonoscopies.  They were entered into the database as the diagnosis of 
SPS was recognized, almost invariably by the senior endoscopist (very few patients 
were referred with the diagnosis of SPS).   
 The endoscopist made surveillance interval recommendations based on 
polyp burden at the end of each colonoscopy.  Endoscopic control was considered 
successful if subsequent examinations exhibited fewer polyps and if no or only an 
occasional polyp ≥1 cm was present at follow-up.  No specified minimum number of 
polyps was required to reach a point considered to be control.  Rather, control was 
considered achieved when the polyp burden based on number and size of lesions 
was substantially reduced from baseline.  The mean number of polyps removed per 
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procedure in the maintenance phase (see results) gives a reasonable sense of the 
residual polyp burden at the point of control.  Patients with cancer or polyps that 
could not be endoscopically resected (eg, a lesion surrounding the appendiceal 
orifice), or who had extensive burdens and indicated a preference for surgery, were 
referred for extended right hemi-colectomy or subtotal colectomy as appropriate.  
We considered endoscopic treatment to occur in 2 phases.  The first phase 
was the clearing phase defined as treatment required to the lower polyp burden 
with intent of achieving endoscopic control.   Thus, the clearing phase required at 
least 2 examinations, including at least one to adequately clear the colon, and 
another to confirm the polyp burden was effectively reduced.  The second phase 
was the maintenance phase defined as procedures performed to maintain control by 
keeping the polyp burden low.  No statistical analysis was performed, as the results 
are descriptive.  
Throughout the study interval polyps <1 cm in size were removed almost 
entirely by cold snaring.  Endoscopic mucosal resection (EMR) was performed 
throughout the study interval using a contrast agent (indigo carmine or methylene 
blue) in the submucosal injectate. Initially the submucosal injection fluid was 
usually saline and later hetastarch.  EMR was performed using snare electrocautery, 
until about 2015, when we began using predominantly cold snare resection to 
perform EMR on serrated lesions 8.  Consistent attempts were made to resect 
normal margins at the polyp edges.  Patients requiring multiple EMRs of lesions in 
the same vicinity often underwent submucosal injection of multiple lesions before 
snare resection of any of the lesions in order to reduce time for passing devices 
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through the colonoscope.  Resection margins of cold snare and EMR sites were 
routinely inspected to identify residual polyp pits and resect them as needed.  The 
registered nurse working in the procedure room was charged with counting the 
polyps removed, including numbers of polyps ≥10 mm and by colon location.  
Procedures were typically scheduled according to the amount of anticipated time 
for resections at 30, 45, 60, or 90 minutes.   In general the approach to reduction of 
polyp burden followed an approach we’ve previously described for control of polyp 
in familial adenomatous polyposis (FAP) 9 (reliance primarily on extensive cold 
snaring), though there were more large polyps requiring EMR than were needed in 
the FAP patients who were considered candidates for endoscopic control.  If the 
work needed to achieve control was not completed in the time allotted time for the 
colonoscopy, then another procedure was scheduled within 3 to 6 months and for a 
procedure duration that reflected the endoscopist’s assessment of the patient’s 
cancer risk based on endoscopic survey of numbers and sizes of polyps not yet 
removed.   Once the polyp burden was under control, the intervals between 
examinations were expanded to 18 to 24 months and occasionally longer intervals. 
Polyps of the same predicted histology and in the same segment of the colon 
were placed in the same formalin bottle for assessment by pathology. Histology was 
predicted endoscopically using criteria expressed in the Narrow Band Imaging 
(NBI) International Colorectal Endoscopic Classification (NICE). 10  Before 2013, no 
standardized histologic definition of sessile serrated polyp was used in the 
pathology department.   Beginning in 2013, the WHO criteria for sessile serrated 
polyp were used. 4  
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Permission to review the de-identified database was granted by the 
Institutional Review Board at Indiana University on June 25, 2018.   
 
 
Results:  
 
 The mean age of the 115 SPS patients at diagnosis was 64.2 years, and 73 
(63.5%) were female.   The indications for the procedure during (or shortly after) 
which the diagnosis was made included screening (n=39), referral for resection of a 
large polyp (n=25),  polyp surveillance (n=24), hematochezia (n=5), history of 
colorectal cancer (n=5), positive fecal blood test (n=4), and miscellaneous (n=13).  
There were 429 colonoscopies performed on 115 patients diagnosed with SPS.   Of 
those, 112 underwent  more than 1 colonoscopy at our center.  Four patients had 
cancer at the prevalence examination and each was operated.  One additional 
patient elected surgery after discussion of a baseline colonoscopy that showed a 
very extensive polyp burden.  Another 5 patients were referred for surgery because 
of polyps that could not be endoscopically resected.  Four of these were because of a 
polyp in the appendiceal orifice that could not be fully exposed for endoscopic 
resection. One patient had a very complex cecal insertion and had a recurrence of a 
right colon serrated lesion that was very difficult to access endoscopically.    At the 
time of this writing, 19 patients diagnosed with SPS had not yet reached control and 
were still in the process of colonoscopic clearing.   The mean total surveillance 
period (time between first and last examination) was 2.1 years, or 25 months.   
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There were 75 patients that met WHO diagnostic criterion 1 only, 2 patients 
meeting criterion 2, 19 patients met criterion 3, and 19 patients met both criteria 1 
and 3.  
In total, 87 patients achieved endoscopic control (Table 2).  The number of 
procedures per patient in those who achieved control ranged from 2 to 8 with a 
range of 1 to 135 polypectomies per procedure. Achieving initial control required a 
mean of 2.84 examinations (range 2-5) over 20.4 months with a mean total 27.9 
(range 5-195) polyp resections (Table 3). There were 4 patients who had more than 
100 polyps removed in the clearing phase and 20 who had ≥10 endoscopic mucosal 
resections (EMRs).   Sessile serrated polyps with cytological dysplasia were found in 
13 patients and ≥1 conventional adenoma in 80 of the patients who achieved 
control.  The largest number of polyps removed in a single colonoscopy was 135 and 
the largest number of EMRs in a single colonoscopy was 32. Recommended follow 
up intervals within the clearing phase included 3, 4, 6, or 12 months.  As expected, 
Type 3 (mean 46.6 polyp resections) and Type 1 and 3 (mean 67.0 resections) 
patients had higher mean numbers of polypectomies in the clearing phase.  Type 1 
patients had fewer mean polypectomies than other types, but had a high mean 
number of large polyps (≥1 cm) at 8.14 per patient.  Patients who met both Types 1 
and 3 criteria had the highest mean number of large polyps at 13.2.    
After establishing control, 71 patients were recommended to return for 
maintenance examinations in ≥24 months due to low polyp burdens.    Of the 
patients recommended to return in ≥24 months, 10 did not seek further treatment 
at our center.  After achieving control, the mean interval between examinations was 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
9 
 
19.3 months with 6.74 mean polypectomies performed per colonoscopy on polyps 
primarily <1 cm in size.   Of 61 patients who returned to our center for maintenance 
colonoscopies, 60 stayed in control.  Of these, 43 returned at intervals that were 
actually ≥24 months, and 18 returned at shorter intervals, in some cases because of 
symptoms. One patient had an increase in polyp burden at follow-up and was 
recommended to return to shorter examination intervals.  No patient developed 
cancer or required surgery during the cleaning or maintenance phase.   
There were 98 patients who had conventional adenomas in addition to the 
serrated lesions present to meet SPS diagnosis.   At this writing, 80 patients with 
conventional adenomas had lowered their polyp burden to the point of control.   
There were no perforations. Two patients had post procedure symptoms 
consistent with postpolypectomy coagulation syndrome (hospitalized for 2 and 3 
days, respectively), and there were no delayed hemorrhages that required 
hospitalization, transfusion, or repeat colonoscopy. 
 
Discussion 
  
In this report we describe one of the largest single center experiences with 
endoscopic management of SPS.   Several multicenter studies from outside the 
United States include larger numbers of SPS patients 5,6.  Compared with these series 
our patient population is skewed toward patients with Type 1 SPS (at least 5 
serrated lesions proximal to the sigmoid with at least 2 >1 cm in size).  Thus, 85% of 
our patients met Type 1 criteria, compared with 55% and 59% in 2 large European 
multicenter studies 5,6.   Further, the number of large polyps resected per patient 
was higher than other series 5,6,11,12.  The number of large lesions and patients with 
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Type 1 SPS almost certainly reflects referral bias because the senior author has 
often identified SPS in patients referred for resection of one or more large serrated 
lesions.  Despite that, we did not encounter incident colorectal cancers during 
surveillance, indicating that endoscopic control of SPS is feasible is patients with 
substantial numbers of large lesions.  Our data indicate that extensive use of EMR is 
both required (based on lesion size) and effective for control of polyp burdens in 
patients that meet Type 1 criteria.  
Others have also recently identified a lower risk of CRC during surveillance of 
SPS than was identified in early studies.   For example, in one study from 18 centers 
in Spain, 296 patients with SPS had an incidence of cancer of 1.9% over 5 years of 
surveillance 5.   We had no incident cancers during surveillance, but we also had 
fewer patients, shorter follow-up, and a single expert endoscopist.  Overall, recent 
studies indicate that SPS patients without cancer at their baseline examination have 
a low incidence of cancer when their colons are aggressively cleared of polyps and 
they continue in surveillance.  We found that substantial numbers of SPS patients 
could reach low polyp burdens that allowed expansion of their surveillance interval 
to two years, and this expansion occurred safely.  Thus, although guidelines 
generally recommend annual surveillance in SPS, our results are consistent with 
others who report using intervals of 1 to 2 years in SPS patients, depending on the 
polyp burden 5,6,12.   Expanding the interval between colonoscopies to 2 years in 
selected patients will reduce costs and burdens of SPS surveillance to patients and 
society. 
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Our impression is that endoscopic control of SPS requires a commitment to 
colonoscopies that are often longer than standard procedures.  Successful control of 
SPS requires a willingness to perform large numbers of polypectomies, including 
numbers of EMRs, in a single procedure.   Success is facilitated by allowing more 
time on the schedule to complete colonoscopy during the clearing phase.  
Anecdotally, “cold EMR” has made clearing the colon easier and less expensive 
because large resection sites in the cecum and proximal colon do not generally need 
clip closure 13 after EMR to prevent delayed adverse events.  
Limitations of this study include its retrospective nature and the imperfect 
follow-up. Nevertheless, a large number of patients did return for follow up and 
comprise a substantial population to establish the safety of surveillance in SPS.  
Second, the patient population is skewed toward SPS Type 1, but the population is 
informative with regard to expected work to achieve polyp control in an SPS 
population with a heavy polyp burden of large lesions.   
In summary, we have demonstrated that the majority of SPS patients can 
realize control of their polyp burdens after a few colonoscopies, and subsequently 
maintain control after expansion of surveillance intervals to 24 months.  Expansion 
of surveillance intervals should increase the acceptance, feasibility, and cost-
effectiveness of surveillance colonoscopy in SPS. 
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Table 1. World Health Organization criteria for SPS * 
 
 
Type 1 – At least 5 serrated polyps** proximal to the sigmoid colon, with at least 2 > 
10 mm in size 
Type 2 – An individual with any number of serrated polyps proximal to the sigmoid 
colon who has a first degree relative of a patient with serrated polyposis syndrome 
Type 3 – At least 20 serrated polyps of any size distributed throughout the colon 
*from reference 4 
** includes sessile serrated polyps/adenomas, hyperplastic polyps and traditional 
serrated adenomas 
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Table 2.  Number and percentage of patients who were diagnosed with SPS, 
achieved control of their polyp burden, and maintained control of polyp burden per 
WHO diagnostic type.  
 Total 
Patients 
Type 1 Type 2 Type 3 Types 
1 and 3* 
 
Diagnosed  
 
115 
 
75  
(65.2%) 
 
2  
(1.7%) 
 
19  
(16.5%) 
 
19  
(16.5%) 
 
 
 
Achieved 
Control 
 
 
 
87  
 
 
 
 
59  
 
 
 
 
1  
 
 
 
 
13  
 
 
 
 
14  
 
 
Cancer at 
Baseline 
 
4 
 
2 
 
 
0 
 
1 
 
1 
 
Required 
Surgery for 
Polyp 
Removal 
 
 
 
5 
 
 
4 
 
 
0 
 
 
1 
 
 
0 
 
Still in 
Clearing 
Phase 
  
 
 
 
19 
 
 
 
 
 
 
10 
 
 
 
 
 
 
1 
 
 
 
 
 
 
4 
 
 
 
 
 
 
4 
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Table 3.  Mean time to achieve endoscopic control, mean number of examinations, 
polyps removed, and large polyps per diagnostic type in the clearing phase.  
 Patients  
who 
achieved 
control 
 
Type 1 
 
Type 2 
 
Type 3 
 
Types 
1 and 3 
 
Mean no. exams 
 
 
2.84(0.87)* 
 
2.95(0.89) 
 
2.0(0.0) 
 
2.50(0.87) 
 
2.93(0.87) 
Mean time 
(months) to 
control 
 
20.4(19.5) 22.2(19.8) 12.0(0.0) 18.5(19.0) 16.0(19.0) 
Mean no. 
polypectomies 
performed per 
patient to achieve 
control 
 
27.9(35.8) 14.0(31.2) 7.0(0.0) 46.6(37.4) 
 
67.0(32.1) 
Mean no. polyps 
≥1 cm resected to 
achieve control 
 
6.39(7.20) 8.14±7.27 1.0(0.0) 2.08(7.61) 13.2(7.59) 
 
 
*Mean (standard deviation) 
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Table 4.  Mean number of examinations obtained by patients, intervals between 
examinations, polypectomies performed per examination, and large polyps in 
patients who received maintenance examinations after obtaining control.  
 All 
patients 
Type 1 Type 2 Type 3 Types 1 
and 3 
 
Mean no. exams 
 
2.7(0.95)* 
 
2.69(0.78) 
 
2.0(0.0) 
 
2.8(0.99) 
 
3.14(0.79) 
 
Mean interval 
between 
 exams (months) 
 
 
19.3(13.5) 
 
 
18.6(13.9) 
 
 
25.0(0.0) 
 
 
21.4(13.0) 
 
 
19.9(14.8) 
 
Mean no. 
polypectomies  
performed per exam 
 
 
6.74(8.21) 
 
 
6.13(7.92) 
 
 
3.0(0.0) 
 
 
9.57(8.18) 
 
 
14.7(8.37) 
 
Mean no. polyps ≥1 
cm  
per exam 
 
 
0.73(0.85) 
 
0.76(0.84) 
 
0.0(0.0) 
 
0.3(0.37) 
 
1.23(1.18) 
 
• Mean (standard deviation) 
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Acronyms: 
SPS: serrated polyposis syndrome 
CRC: colorectal cancer 
Cm: centimeters 
WHO: The World Health Organization 
PA: Pennsylvania  
DKR: Douglas K. Rex 
EMR: endoscopic mucosal resection 
Mm: millimeters 
FAP: familial adenomatous polyposis 
U.S.: United States 
 
